MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, UNCY has $64,406K in assets. $26,702K in debts. $37,371K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
239.93%
Quick Ratio
239.93%
Cash Ratio
141.10%
Debt to Asset Ratio
41.46%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Right of use asset, net
    • Less accumulated depreciation
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Warrant liability
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
37,371 29,198 42,695 22,327
Prepaid expenses and other current assets
8,959 7,692 7,592 7,199
Marketable securities
17,215 12,071 --
Total current assets
63,545 48,961 50,287 29,526
Right of use asset, net
813 108 249 386
Subtotal
106 138 138 -
Less accumulated depreciation
58 72 63 -
Property and equipment, net
48 66 75 83
Total assets
64,406 49,135 50,611 29,995
Accounts payable
1,140 383 957 775
Accrued liabilities
3,052 1,523 2,762 2,168
Warrant liability
21,695 16,915 9,147 10,214
Operating lease liability - current
598 117 265 409
Preferred stock, value-Series A2Preferred Stock
--0 0
Total current liabilities
26,485 18,938 13,131 13,566
Preferred stock, value-Series B2Preferred Stock
--0 0
Operating lease liability long term
217 -0 0
Preferred stock, value
--0 0
Total liabilities
26,702 18,938 13,131 13,566
Common stock, 0.001 par value per share 400,000,000 shares authorized at december 31, 2025, and march 31, 2026 22,114,245 and 25,237,782 shares issued and outstanding at december 31, 2025, and march 31, 2026, respectively
25 22 21 122
Accumulated other comprehensive (loss) income
6 -1 --
Additional paid-in capital
178,321 158,001 150,617 123,454
Accumulated deficit
-140,648 -127,825 -113,158 -107,147
Total stockholders equity
37,704 30,197 37,480 16,429
Total liabilities and stockholders equity
64,406 49,135 50,611 29,995
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$37,371K Marketable securities$17,215K Prepaid expenses andother current assets$8,959K Subtotal$106K Total current assets$63,545K Right of use asset, net$813K Property and equipment,net$48K Less accumulateddepreciation$58K Total assets$64,406K Total liabilities andstockholders equity$64,406K Total stockholdersequity$37,704K Total liabilities$26,702K Accumulated deficit-$140,648K Additional paid-in capital$178,321K Total currentliabilities$26,485K Operating lease liability long term$217K Common stock, 0.001 parvalue per share ...$25K Accumulated othercomprehensive (loss) income$6K Warrant liability$21,695K Accrued liabilities$3,052K Accounts payable$1,140K Operating lease liability- current$598K

Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics, Inc. (UNCY)